All lobbying filings

The Nickles Group, LLC

The Nickles Group, LLC filed a Q2 report for Jazz Pharmaceuticals, Inc. on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Jazz Pharmaceuticals, Inc. · Pharmaceutical company.

As filed: THE NICKLES GROUP, LLC for JAZZ PHARMACEUTICALS, INC.

All filings by The Nickles Group, LLC · Everything Jazz Pharmaceuticals, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 1

MOLLY FROMM New on this filing

Previously held: (continued) U.S. House Cmte on Oversight and Government Reform, Deputy General Counsel, Parliamentarian, Professional Staff Member; U.S. Rep. Darrell Issa, Leg. Asst., Leg. Corr., Staff Asst., Intern

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues related to Most Favored Nation drug pricing. Issues related to orphan drugs.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.